Revolutionize Collaboration and Accelerate Growth

Meitheal Pharmaceuticals, Chicago, IL, Generics. Add'l Locations Novian Health ... Xentria, Chicago, IL, Biologics & Biosimilars, Monoclonal Antibody. Add'l ... Meitheal Pharmaceuticals, Chicago, IL, Generics. Novian Health, Chicago, IL ... Xentria, Chicago, IL, Biologics & Biosimilars, Monoclonal Antibody. Xeris ... Xentria Inc a clinicalstage biotherapeutics company focused on developing therapeutics to address unmet clinical needs and Meitheal Pharmaceuticals Inc today ... 方代表”）及香港健友控股子公司Meitheal Pharmaceuticals, Inc.（以下简. 称“Meitheal”“被许可方”）拟与Xentria 签署《许可、开发与商业化协议》. Xentria's Multi-Year Licensing Agreement with Meitheal. By Martina Bellini. Perkins Coie advised Xentria Inc. on the deal. Xentria Inc., a clinical-stage ... Immunology. Study Phase : Phase I/ Phase II. Recipient : Xentria. Deal Size : $680.0 million. Deal Type : Licensing Agreement. DEALS_DEV arrow-down · Xentria ... Xentria Inc./Meitheal. Pharmaceuticals Inc. In clinical trials. Molecule. Innovator product (company) Biosimilars. Company. Status. Omalizumab. Xolair® ( ... ... Meitheal拟与Xentria签署《许可协议》，Xentria授予被许可方在许可 ... Xentria,Inc（以下简称“Xentria”）目前不属于上市公司，公司未查询到其 ... Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development ... The Growing Crisis of Antimicrobial Resistance: Meitheal ... In a significant ... In addition, Victoria is the General Counsel & Corporate Secretary of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was ...